Adrienne Davies

Adrienne Davies, PhD, serves as the Director of Regulatory Affairs CMC at BioMarin Pharmaceutical Inc. since June 2025. Previously, Adrienne held senior leadership roles in regulatory affairs at Allakos Inc., including Senior Director and Director, where key responsibilities involved defining CMC regulatory strategies, advising on regulatory requirements, and leading risk management discussions. Adrienne's extensive background includes various positions at Regeneron Pharmaceuticals, contributing to successful regulatory submissions for clinical development and commercialization of products. Adrienne began a research career with a PhD in Industrial Microbiology from the University of Warwick, supported by a Master's Degree and an Honours Bachelor of Science from the same institution and the University of Toronto, respectively.